Literature DB >> 19888614

[Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice].

L Rinnab1, M Ringhoffer, R Mayer-Steinacker, R E Hautmann, J Simon.   

Abstract

Extravasation of chemotherapeutic agents is a rare (1-6%) but potentially severe iatrogenic complication of systemic therapy. Depending on the cytotoxic agent, tissue damage and necrosis may occur, followed by a delay in administration of chemotherapy, prolonged hospitalization, impaired function, and the need for tissue excision. Therefore, optimal placement of the intravenous catheter is absolutely necessary to reduce the risk of extravasation. The aim of this report is to give urologists a practical and useful guide on how to prevent, diagnose, and treat this complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888614     DOI: 10.1007/s00120-009-2103-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

Review 1.  Evaluation and treatment of chemotherapy extravasation injuries.

Authors:  E Kassner
Journal:  J Pediatr Oncol Nurs       Date:  2000-07       Impact factor: 1.636

2.  Antineoplastic vesicant extravasation.

Authors:  R Beason
Journal:  J Intraven Nurs       Date:  1990 Mar-Apr

3.  IV infiltration no clear signs, no clear treatment?

Authors:  M Hastings-Tolsma; C B Yucha
Journal:  RN       Date:  1994-12

4.  Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

Authors:  R J Ignoffo; M A Friedman
Journal:  Cancer Treat Rev       Date:  1980-03       Impact factor: 12.111

5.  Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

Authors:  H T Mouridsen; S W Langer; J Buter; H Eidtmann; G Rosti; M de Wit; P Knoblauch; A Rasmussen; K Dahlstrøm; P B Jensen; G Giaccone
Journal:  Ann Oncol       Date:  2006-12-21       Impact factor: 32.976

6.  [Early and late treatment of iatrogenic injection damage].

Authors:  D von Heimburg; N Pallua
Journal:  Chirurg       Date:  1998-12       Impact factor: 0.955

Review 7.  Vesicant extravasation: myths and realities.

Authors:  D M Boyle; C Engelking
Journal:  Oncol Nurs Forum       Date:  1995 Jan-Feb       Impact factor: 2.172

Review 8.  Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.

Authors:  R Rudolph; D L Larson
Journal:  J Clin Oncol       Date:  1987-07       Impact factor: 44.544

9.  Minimal surgical debridement for the treatment of chemotherapeutic agent-induced skin extravasations.

Authors:  T S Loth
Journal:  Cancer Treat Rep       Date:  1986-03

Review 10.  Two case reports of vinorelbine extravasation: management and review of the literature.

Authors:  S Cicchetti; B Jemec; D T Gault
Journal:  Tumori       Date:  2000 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.